 NEW YORK, March 18, 2021 PRNewswire -- Relmada Therapeutics, Inc. Nasdaq: RLMD, a late-stage biotechnology company addressing diseases of the central nervous system CNS, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2020 after the market close on Tuesday, March 23, 2021. The company will host a corporate update conference call and live audio webcast at 4:30 PM Eastern Time on Tuesday, March 23, 2021. 